ASX:PMEHealthcare Services
A Look At Pro Medicus’s Valuation As AI Jitters Pressure Tech Stocks And Create A Possible Opening
Recent volatility in technology stocks, driven by concerns about the impact of AI on valuations, has pushed Pro Medicus (ASX:PME) sharply lower and prompted some investors to reassess the medical imaging specialist.
See our latest analysis for Pro Medicus.
Those AI related worries have come on top of already weak momentum, with a 30 day share price return of 20.24% and a 90 day share price return of 34.82%. The 1 year total shareholder return of 42.43% contrasts with a very large 3 year total...